MedPath
Found 171 clinical trials|View Analysis
Sort by:

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

Early Phase 1
Not yet recruiting
Conditions
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
Interventions
First Posted Date
2024-12-24
Last Posted Date
2024-12-30
Lead Sponsor
University of Minnesota
Target Recruit Count
40
Registration Number
NCT06747611

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

Phase 1
Recruiting
Conditions
Alopecia Areata
Vitiligo
Interventions
First Posted Date
2024-09-19
Last Posted Date
2025-01-01
Lead Sponsor
Dren Bio
Target Recruit Count
60
Registration Number
NCT06602232
Locations
🇳🇿

Dren Investigational Site, Grafton, New Zealand

Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study

Recruiting
Conditions
Janus Kinase Inhibitors
Alopecia Areata
Interventions
First Posted Date
2024-08-27
Last Posted Date
2024-08-27
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Target Recruit Count
150
Registration Number
NCT06573593
Locations
🇨🇳

Second Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, China

Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata

Not Applicable
Recruiting
Conditions
Alopecia Areata
Interventions
Drug: Candida Albicans Antigen Injection
First Posted Date
2024-08-21
Last Posted Date
2024-08-21
Lead Sponsor
Universidad Autonoma de Nuevo Leon
Target Recruit Count
30
Registration Number
NCT06564805
Locations
🇲🇽

Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo León, Mexico

A Phase II Study of SYHX1901 Tablets in the Treatment of Severe Alopecia Areata

Phase 2
Not yet recruiting
Conditions
Severe Alopecia Areata
Interventions
Drug: SYHX1901
Drug: Placebo
First Posted Date
2024-08-20
Last Posted Date
2024-08-20
Lead Sponsor
CSPC Ouyi Pharmaceutical Co., Ltd.
Target Recruit Count
156
Registration Number
NCT06562894

CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

Recruiting
Conditions
Alopecia Areata
First Posted Date
2024-08-20
Last Posted Date
2025-01-09
Lead Sponsor
CorEvitas
Target Recruit Count
1500
Registration Number
NCT06562270
Locations
🇺🇸

CorEvitas, LLC, Waltham, Massachusetts, United States

Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib

Phase 1
Active, not recruiting
Conditions
Alopecia Areata
Interventions
First Posted Date
2024-08-09
Last Posted Date
2024-08-09
Lead Sponsor
South Valley University
Target Recruit Count
120
Registration Number
NCT06545110
Locations
🇪🇬

South Valley University, Qinā, الكيلو 6 Qena - Safaga Rd, Qena, Qena Governorate, Egypt

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

Recruiting
Conditions
Alopecia Areata
Interventions
First Posted Date
2024-07-31
Last Posted Date
2024-11-25
Lead Sponsor
Pfizer
Target Recruit Count
850
Registration Number
NCT06531109
Locations
🇺🇸

Cura Clinical Research, Oxnard, California, United States

🇺🇸

Pediatric Skin Research,LLC, Coral Gables, Florida, United States

🇺🇸

Suncoast Skin Solutions, Jacksonville, Florida, United States

and more 8 locations

A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata

Early Phase 1
Completed
Conditions
Alopecia Areata
Interventions
Drug: sildenafil-loaded liposomes
Drug: minoxidil gel
First Posted Date
2024-07-30
Last Posted Date
2024-07-30
Lead Sponsor
Assiut University
Target Recruit Count
28
Registration Number
NCT06527729
Locations
🇪🇬

Faculty of Medicine, Assiut university, Assiut, Egypt

Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA)

Active, not recruiting
Conditions
Alopecia Areata
First Posted Date
2024-06-24
Last Posted Date
2024-06-24
Lead Sponsor
University Hospital, Brest
Target Recruit Count
250
Registration Number
NCT06471114
Locations
🇫🇷

Chu Brest, Brest, France

© Copyright 2025. All Rights Reserved by MedPath